Frank Rimerman Advisors’s Hologic HOLX Stock Holding History

Frank Rimerman Advisors’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,888	Closed	-$369K	–	629
2026 Q1	$369K	Buy	4,888 +739	+18%	+$55.6K	0.02%	442
2025 Q4	$309K	Buy	4,149 +14	+0.3%	+$1.02K	0.02%	499
2025 Q3	$279K	Buy	4,135 +20	+0.5%	+$1.33K	0.02%	498
2025 Q2	$268K	Sell	4,115 -1,861	-31%	-$112K	0.02%	481
2025 Q1	$369K	Buy	5,976 +549	+10%	+$36.4K	0.03%	369
2024 Q4	$391K	Buy	5,427 +472	+10%	+$36.9K	0.03%	359
2024 Q3	$404K	Sell	4,955 -44	-0.9%	-$3.52K	0.03%	368
2024 Q2	$371K	Buy	+4,999	New	+$375K	0.03%	409

Other funds holding HOLX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Frank Rimerman Advisors's HOLX Position: Q2 2026 in Review

Frank Rimerman Advisors sold out of Hologic (HOLX) in Q2 2026, closing a stake of 4,888 shares — an estimated $369K sold.

Frank Rimerman Advisors first reported a position in HOLX in Q2 2024 and held it in 8 quarters. The position peaked at $404K in Q3 2024. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

Frank Rimerman Advisors reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
Frank Rimerman Advisors sold 4,888 Hologic shares in Q2 2026, an estimated $369K.
Frank Rimerman Advisors first reported a position in Hologic in Q2 2024 and held it in 8 quarters.
Frank Rimerman Advisors's Hologic position peaked at $404K in Q3 2024.
3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Frank Rimerman Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.